The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Engineered CRISPR-Cas9 nuclease with expanded targeting space
Open accessAbstract
Cas9 enzyme (SpCas9) requires an NGG protospacer adjacent motif (PAM) for target recognition, thereby restricting the targetable genomic loci. Here, we report a rationally engineered SpCas9 variant (SpCas9-NG) that can recognize relaxed NG PAMs. The crystal structure revealed that the loss of the base-specific interaction with the third nucleobase is compensated by newly introduced non-base-specific interactions, thereby enabling the NG PAM recognition. We showed that SpCas9-NG induces indels at endogenous target sites bearing NG PAMs in human cells. Furthermore, we found that the fusion of SpCas9-NG and the activation-induced cytidine deaminase (AID) mediates the C-to-T conversion at target sites with NG PAMs in human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These can be targeted in combination with evolved Cas9 variants such as SpCas9-NG20 or SpG.19”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A rationally engineered SpCas9 variant (SpCas9-NG) generated based on the reduced interaction between the third nucleobase of PAMs and the gRNA-Cas9 complex could edit the target site with NG PAMs.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationProgrammable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Self-citationHow good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,713
Molecular replacement with MOLREP
Vagin, A. A., & Teplyakov, A. (2009) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042589 · Cited by 3,580
Flagged first, then by citations
1 of the 25 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,001
Huang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
Xia, K., Wang, F., Tan, Z., Zhang, S., Lai, X., Ou, W., Yang, C., Chen, H., Peng, H. Y., Luo, P., et al. (2023) · Advanced Science · doi:10.1002/advs.202300993 · Cited by 20
Unbiased interrogation of functional lysine residues in human proteome
Bao, Y., Pan, Q., Xu, P., Liu, Z., Zhang, Z., Liu, Y., Xu, Y., Yu, Y., Zhou, Z. L., & Wei, W. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.033 · Cited by 19
Target DNA-dependent activation mechanism of the prokaryotic immune system SPARTA
Finocchio, G., Koopal, B., Potocnik, A., Heijstek, C., Westphal, A. H., Jínek, M., & Swarts, D. C. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1248 · Cited by 20
Health research in the era of artificial intelligence: Advances in gene-editing study
Dai, M., Li, X., Zhang, Q., Liang, T., Huang, X., & Fu, Q. (2024) · Medicine Plus · doi:10.1016/j.medp.2024.100027 · Cited by 19
Blossom of CRISPR technologies and applications in disease treatment
Liu, H., Wang, L., & Luo, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.10.003 · Cited by 19
Erwood, S., Brewer, R. A., Bily, T. M. I., Maino, E., Zhou, L., Cohn, R. D., & Ivakine, E. A. (2019) · Genome Research · doi:10.1101/gr.250720.119 · Cited by 20
Base Editing in Human Cells to Produce Single‐Nucleotide‐Variant Clonal Cell Lines
Vásquez, C. A., Cowan, Q. T., & Komor, A. C. (2020) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.129 · Cited by 20
Wang, S., Tao, C., Mao, H., Hou, L., Wang, Y., Qi, T., Yang, Y., Ong, S., Hu, S., Chai, R., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001897 · Cited by 18
Precise genome editing with base editors
Liu, H., Zhu, Y., Li, M., & Gu, Z. (2023) · Medical Review · doi:10.1515/mr-2022-0044 · Cited by 19
Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Dictyostelium
Muramoto, T., Iriki, H., Watanabe, J., & Kawata, T. (2019) · Cells · doi:10.3390/cells8010046 · Cited by 19
Rabinowitz, R., Abadi, S., Almog, S., & Offen, D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa215 · Cited by 18
CRISPR-Guided Programmable Self-Assembly of Artificial Virus-Like Nucleocapsids
Calcines-Cruz, C., Finkelstein, I. J., & Hernández-García, A. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04640 · Cited by 18
Advances in Accurate Microbial Genome-Editing CRISPR Technologies
Lee, H. J., & Lee, S. J. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2106.06056 · Cited by 19
Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
Yee, T., & Wert, K. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012375 · Cited by 21
Celotti, M., Derks, L. L. M., van Es, J., van Boxtel, R., Clevers, H., & Geurts, M. H. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103189 · Cited by 17
A streamlined base editor engineering strategy to reduce bystander editing
Valdez, I., O’Connor, I., Patel, D., Gierer, K., Harrington, J., Ellis, E., Caponetti, S. A., Sebra, R., Valley, H. C., Coote, K. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63609-6 · Cited by 17
Advances and Applications of Plant Base Editing Technologies
Peng, H. F., Li, J., Sun, K., Tang, H., Huang, W., Li, X., Wang, S., Ding, K., Han, Z., Li, Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199452 · Cited by 20
Heo, Y. B., Hwang, G., Kang, S. W., Bae, S., & Woo, H. M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03760-22 · Cited by 17
Genome editing for vegetatively propagated crops improvement: a new horizon of possibilities
Lakhani, H., Thakur, N., & Tiwari, S. (2022) · Journal of Plant Biochemistry and Biotechnology · doi:10.1007/s13562-022-00819-9 · Cited by 17
The Wild‐Type tRNA Adenosine Deaminase Enzyme TadA Is Capable of Sequence‐Specific DNA Base Editing
Ranzau, B. L., Rallapalli, K. L., Evanoff, M., Paesani, F., & Komor, A. C. (2023) · ChemBioChem · doi:10.1002/cbic.202200788 · Cited by 17
CRISPR/Cas in Grapevine Genome Editing: The Best Is Yet to Come
Ren, C., Mohamed, M. S. M., Aini, N., Kuang, Y., & Liang, Z. (2024) · Horticulturae · doi:10.3390/horticulturae10090965 · Cited by 18
Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy
Borot, F., Humbert, O., Ehmsen, J. T., Fields, E., Kohli, S., Radtke, S., Swing, K., Pande, D., Enstrom, M., Laszlo, G. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59713-2 · Cited by 17
Versatile transcription control based on reversible dCas9 binding
Widom, J. R., Rai, V., Rohlman, C. E., & Walter, N. G. (2019) · RNA · doi:10.1261/rna.071613.119 · Cited by 18
Advances in CRISPR/Cas9-mediated genome editing on vegetable crops
Tian, S., Xing, S., & Xu, Y. (2021) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-021-10187-z · Cited by 17
Perfecting Targeting in CRISPR
Zhang, H., Li, T., Sun, Y., & Yang, H. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-030438 · Cited by 18
CRISPR/Cas correction of muscular dystrophies
Zhang, Y., Nishiyama, T., Olson, E. N., & Bassel‐Duby, R. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112844 · Cited by 18
Base editing the mammalian genome
Schatoff, E. M., Zafra, M. P., & Dow, L. E. (2019) · Methods · doi:10.1016/j.ymeth.2019.02.022 · Cited by 20
Base editing in Streptomyces with Cas9-deaminase fusionsPreprint
Zhong, Z., Guo, J., Deng, L., Chen, L., Wang, J., Li, S., Xu, W. Q., Deng, Z., & Sun, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/630137 · Cited by 17
Mitsunobu, H., Kita, Y., Nambu-Nishida, Y., Miyazaki, S., Nakajima, K., Taoka, K.-I., Kondo, A., & Nishida, K. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-025-13489-z · Cited by 16
Engineering eukaryotic transposon-encoded Fanzor2 system for genome editing in mammals
Wei, Y., Gao, P., Pan, D., Li, G., Chen, Y., Li, S., Jiang, H., Yang, Y., Liu, Z., Liu, Z., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01902-7 · Cited by 16
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing
Castiello, M. C., Ferrari, S., & VILLA, A. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101731 · Cited by 16
Joynt, A. T., Kavanagh, E. W., Newby, G. A., Mitchell, S., Eastman, A. C., Paul, K. C., Bowling, A. D., Osorio, D. L., Merlo, C. A., Patel, S. U., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.06.020 · Cited by 16
Ahn, Y., An, J.-H., Yang, H.-J., Lee, W.-J., Lee, S., Park, Y., Lee, J. H., Lee, H. J., Lee, S. H., & Kim, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04141-4 · Cited by 16
Yuan, Y., Liu, S.-Z., Farhab, M., Lv, M.-Y., Zhang, T., & Cao, S.-X. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01364-5 · Cited by 18
Banda, A., Impomeni, O., Singh, A., Baloch, A. R., Hu, W., & Jaijyan, D. K. (2024) · Vaccines · doi:10.3390/vaccines12060636 · Cited by 16
DNA targeting by compact Cas9d and its resurrected ancestor
Ocampo, R. F., Bravo, J. P. K., Dangerfield, T. L., Nocedal, I., Jirde, S. A., Alexander, L. M., Thomas, N. C., Das, A., Nielson, S., Johnson, K. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55573-4 · Cited by 17
Jyoti, A., Kaushik, S., Srivastava, V. K., Datta, M., Kumar, S., Yugandhar, P., Kothari, S. L., Rai, V., & Jain, A. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.03.010 · Cited by 17
‘Artificial spermatid’-mediated genome editing†
Wang, L., & Li, J. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz087 · Cited by 16
Shestovskaya, M. V., Божкова, С. А., Sopova, J. V., Георгиевич, Х. М., & Bozhokin, M. S. (2021) · Biomedicines · doi:10.3390/biomedicines9111666 · Cited by 16
Park, J.-C., Kim, J., Jang, H., Lee, S., Kim, K.-T., Kwon, E., Park, S., Lee, H. S., Choi, H., Park, S., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121419 · Cited by 16
Rehman, R. S., Zafar, S. A., Ali, M., Pasha, A. N., Naveed, M. S., Waseem, M., Ahmad, M., & Raza, A. (2022) · Asian Plant Research Journal · doi:10.9734/aprj/2022/v9i130197 · Cited by 16
Feng, S., Liang, L., Shen, C., Lin, D., Li, J., Lyu, L., Liang, W., Zhong, L., Cook, G. M., Doi, Y., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.004 · Cited by 16
Cheng, Y., Zhang, N., Hussain, S., Ahmed, S., Yang, W., & Wang, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218583 · Cited by 17
Correction of the pathogenic mutation in TGM1 gene by adenine base editing in mutant embryos
Dang, L., Zhou, X., Zhong, X., Yu, W., Huang, S., Liu, H., Chen, Y., Zhang, W., Yuan, L., Li, L., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.007 · Cited by 16
Malbranke, C., Rostain, W., Depardieu, F., Cocco, S., Monasson, R., & Bikard, D. (2023) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1011621 · Cited by 15
Emerging trends in gene and cell therapy: CRISPR in DNA editing and beyond
Ji, R., Chen, Q., & Zhang, Y. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102459 · Cited by 14
Generation of genetically modified mice using SpCas9-NG engineered nuclease
Fujii, W., Ito, H., Kanke, T., Ikeda, A., Sugiura, K., & Naito, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-49394-5 · Cited by 16
In vivo application of base and prime editing to treat inherited retinal diseases
Jo, D. H., Bae, S., Kim, S., Kim, J., & Kim, J. H. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101132 · Cited by 15
Zheng, X., Cairns, T. C., Zheng, P., Meyer, V., & Sun, J. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101838 · Cited by 15
Decoding CRISPR–Cas PAM recognition with UniDesign
Huang, X., Zhou, J., Yang, D., Zhang, J., Xia, X., Chen, Y. E., & Xu, J. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad133 · Cited by 16
Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
Gapinske, M., Winter, J., Swami, D., Gapinske, L., Woods, W. S., Shirguppe, S., Miskalis, A., Busza, A. M., Joulani, D., Kao, C. J., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.07.029 · Cited by 16
DNA-GPS: A theoretical framework for optics-free spatial genomics and synthesis of current methods
Greenstreet, L., Afanassiev, A., Kijima, Y., Heitz, M., Ishiguro, S., King, S. B., Yachie, N., & Schiebinger, G. R. (2023) · Cell Systems · doi:10.1016/j.cels.2023.08.005 · Cited by 15
Self-citationGenome and transcriptome engineering by compact and versatile CRISPR-Cas systems
Aquino‐Jarquín, G. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103793 · Cited by 15
Cazier, A. P., Irvin, O. M., Chávez, L. S., Dalvi, S., Abraham, H., Wickramanayake, N., Yellayi, S., & Blazeck, J. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00299 · Cited by 15
Precise base editing without unintended indels in human cells and mouse primary myoblasts
Yoon, D. E., Kim, N., Park, S.-J., Jeong, T. Y., Eun, B., Cho, Y., Lim, S., Lee, H., Seong, J. K., & Kim, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01128-4 · Cited by 15
The immune system of prokaryotes: potential applications and implications for gene editing
Liu, S. M., Liu, H., Wang, X., & Shi, L. (2024) · Biotechnology Journal · doi:10.1002/biot.202300352 · Cited by 16
Genome editing in grass plants
Char, S. N., & Yang, B. (2019) · aBIOTECH · doi:10.1007/s42994-019-00005-x · Cited by 15
Chen, Y., Fang, L., Ying, X., Cheng, M., Wang, L., Sun, P., Zhang, Z., Shi, L., Cao, Y., & Song, H. (2022) · Advanced Biology · doi:10.1002/adbi.202101296 · Cited by 15
Wang, J., Teng, Y., Gong, X., Zhang, J., Wu, Y., Lou, L., Li, M., Xie, Z., & Yan, Y. (2022) · Metabolic Engineering · doi:10.1016/j.ymben.2022.10.005 · Cited by 16
Genome editing with natural and engineered CjCas9 orthologs
Gao, S., Wang, Y., Qi, T., Wei, J., Hu, Z., Liu, J., Sun, S., Liu, H., & Wang, Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.029 · Cited by 16
Engineering CRISPR-Cas9 RNA–Protein Complexes for Improved Function and Delivery
Rouet, R., de Oñate, L., Li, J., Murthy, N., & Wilson, R. C. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0037 · Cited by 16
Improving Editing Efficiency for the Sequences with NGH PAM Using xCas9-Derived Base Editors
Liu, X., Li, G., Zhou, X., Qiao, Y., Wang, R., Tang, S., Liu, J., Wang, L., & Huang, X. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.06.024 · Cited by 15
Narra, M., Ray, A., Polley, B., Yang, H., & Bhowmik, P. (2025) · Frontiers in Plant Science · doi:10.3389/fpls.2025.1718810 · Cited by 16
Efficient base editing in tomato using a highly expressed transient system
Yuan, S., Kawasaki, S., Abdellatif, I. M. Y., Nishida, K., Kondo, A., Ariizumi, T., Ezura, H., & Miura, K. (2021) · Plant Cell Reports · doi:10.1007/s00299-021-02662-z · Cited by 14
Design and application of the transformer base editor in mammalian cells and mice
Han, W., Gao, B., Zhu, J., He, Z., Li, J., Yang, L. C., & Chen, J. (2023) · Nature Protocols · doi:10.1038/s41596-023-00877-w · Cited by 15
Analyzing the functional effects of DNA variants with gene editing
Cooper, S., Obolenski, S., Waters, A. J., Bassett, A. R., & Coelho, M. A. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100776 · Cited by 14
Current Knowledge of Base Editing and Prime Editing
Averina, O. A., Kuznetsova, S. A., Permyakov, O. A., & Владимирович, С. П. (2024) · Molecular Biology · doi:10.1134/s0026893324700195 · Cited by 14
Yin, S., Gao, L., Sun, X., Zhang, M., Gao, H.-Y., Chen, X., Zhang, D., Ming, X., Yang, L., Hu, Y., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.032 · Cited by 14
Self-citationCRISPR-Cas Systems: A Functional Perspective and Innovations
Navarro, C., Diaz, M. P., Durán, P., Castro, A., Díaz, A., Cano, C., Carbonell, A., Solano-Jimenez, D.-S., Rivera-Porras, D., Contreras-Velásquez, J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083645 · Cited by 16
CRISPR-based functional genomics tools in vertebrate models
Varshney, G. K., & Burgess, S. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01514-0 · Cited by 18
The Acidaminococcus sp. Cas12a nuclease recognizes GTTV and GCTV as non-canonical PAMs
Jacobsen, T. L., Liao, C., & Beisel, C. L. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz085 · Cited by 15
Genome Editing Technology and Its Application to Metabolic Engineering in Rice
Sukegawa, S., Toki, S., & Saika, H. (2022) · Rice · doi:10.1186/s12284-022-00566-4 · Cited by 15
Comprehending the evolution of gene editing platforms for crop trait improvement
Dhakate, P., Sehgal, D., Vaishnavi, S., Chandra, A., Singh, A., Raina, S. N., & Rajpal, V. R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.876987 · Cited by 14
The Power of Gene Technologies: 1001 Ways to Create a Cell Model
Karagyaur, M. N., Primak, A. L., Efimenko, A. Y., Никитична, С. М., & Va, T. (2022) · Cells · doi:10.3390/cells11203235 · Cited by 14
Evaluation of genome and base editing tools in maize protoplasts
Fierlej, Y., Jacquier, N. M. A., Guille, L., Just, J., Montes, É., Richard, C., Loue-Manifel, J., Depège‐Fargeix, N., Gaillard, A., Widiez, T., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.1010030 · Cited by 15
Enhancing the quality of staple food crops through CRISPR/Cas-mediated site-directed mutagenesis
Adeyinka, O. S., Tabassum, B., Landry, K. B., & Ogungbe, I. V. (2023) · Planta · doi:10.1007/s00425-023-04110-6 · Cited by 16
Enhancing prime editor flexibility with coiled-coil heterodimers
Mu, S., Chen, H., Li, Q., Gou, S., Liu, X., Wang, J., Zheng, W., Chen, M., Jin, Q., Lai, L., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03257-z · Cited by 14
Current trends in gene therapy to treat inherited disorders of the brain
Matuszek, Ż., Brown, B. L., Yrigollen, C. M., Keiser, M. S., & Davidson, B. L. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.057 · Cited by 13
Why Does the E1219V Mutation Expand T-Rich PAM Recognition in Cas9 from Streptococcus pyogenes?
Bhattacharya, S., & Satpati, P. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01515 · Cited by 13
Gene editing therapy for cardiovascular diseases
Wu, X., Yang, J., Zhang, J., & Song, Y. (2024) · MedComm · doi:10.1002/mco2.639 · Cited by 14
Advancements of CRISPR-Mediated Base Editing in Crops and Potential Applications in Populus
Yang, X., Zhu, P., & Gui, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158314 · Cited by 13
Kulhánková, K., Cheng, A. X., Traore, S., Auger, M., Pelletier, M., Hervault, M., Wells, K. D., Green, J. A., Byrne, A. K., Nelson, B., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae819 · Cited by 14
Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii
Ferenczi, Á., Fellbaum, M., Chew, Y. P., Kidner, C. A., & Molnár, A. (2024) · Algal Research · doi:10.1016/j.algal.2024.103796 · Cited by 13
Hu, S. W., Jeong, S., Jiang, L., Koo, H., Wang, Z., Choi, W. H., Zhu, B., Seok, H., Zhou, Y., Kim, M. G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62562-8 · Cited by 13
Treatment of a severe vascular disease using a bespoke CRISPR–Cas9 base editor in mice
Alves, C. R. R., Das, S., Krishnan, V., Ha, L. L., Fox, L. R., Stutzman, H. E., Shamber, C., Kalailingam, P., McCarthy, S., Cardenas, C. L. L., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01499-1 · Cited by 16
The Gene Sculpt Suite: a set of tools for genome editing
Mann, C. M., Martínez‐Gálvez, G., Welker, J. M., Wierson, W. A., Ata, H., Almeida, M. P., Clark, K. J., Essner, J. J., McGrail, M. A., Ekker, S. C., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz405 · Cited by 13
Neggers, J. E., Jacquemyn, M., Dierckx, T., Kleinstiver, B. P., Thibaut, H. J., & Daelemans, D. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.025 · Cited by 13
Yoshioka, I., & Kirimura, K. (2021) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2021.01.011 · Cited by 13
Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better?
Lv, J., Xi, H., Lv, X., Zhou, Y., Wang, J., Chen, H., Yan, T., Jin, J., Zhao, J., Gu, F., et al. (2022) · Gene Therapy · doi:10.1038/s41434-022-00319-4 · Cited by 14
Expanding the Editing Window of Cytidine Base Editors With the Rad51 DNA-Binding Domain in Rice
Wei, C., Liu, H., Wang, W., Luo, P., Chen, Q., Li, R., Wang, C., Botella, J. R., & Zhang, H. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.865848 · Cited by 13
Development and expansion of the CRISPR/Cas9 toolboxes for powerful genome engineering in yeast
Guang, C., Lin, Z., & Shi, S. (2022) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2022.110056 · Cited by 14
Kulcsár, P. I., Tálas, A., Ligeti, Z., Tóth, E., Rakvács, Z., Bartos, Z., Krausz, S. L., Welker, Á., Végi, V. L., Huszár, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41393-5 · Cited by 14
Engineering CRISPR guide RNAs for programmable RNA sensors
Liu, Y., Liu, W. Y., & Wang, B. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221486 · Cited by 13
Lu, Y., Ronald, P. C., Han, B., Li, J., & Zhu, J. (2020) · Molecular Plant · doi:10.1016/j.molp.2020.11.006 · Cited by 13
Translational potential of base-editing tools for gene therapy of monogenic diseases
Reshetnikov, V. V., Chirinskaite, A. V., Sopova, J. V., Ivanov, R. A., & Леонова, Е. И. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.942440 · Cited by 13
Rewriting Human History and Empowering Indigenous Communities with Genome Editing Tools
Fox, K., Rallapalli, K. L., & Komor, A. C. (2020) · Genes · doi:10.3390/genes11010088 · Cited by 13
A long shelf-life melon created via CRISPR/Cas9 RNP-based in planta genome editing
Sasaki, K., Urano, K., Mimida, N., Nonaka, S., Ezura, H., & Imai, R. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1623097 · Cited by 12
Molecular and Computational Strategies to Increase the Efficiency of CRISPR-Based Techniques
Mattiello, L., Rütgers, M., Sua-Rojas, M. F., Tavares, R., Soares, J. S., Begcy, K., & Menossi, M. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.868027 · Cited by 12
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
Li, R., Wang, Q., She, K., Lu, F., & Yang, Y. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00095-y · Cited by 13
Metadata
- Authors
- Nishimasu, H., Shi, X., Ishiguro, S., Gao, L., Hirano, S., Okazaki, S., Noda, T., Abudayyeh, O. O., Gootenberg, J. S., Mori, H., Oura, S., Holmes, B., Tanaka, M., Seki, M., Hirano, H., Aburatani, H., Ishitani, R., Ikawa, M., Yachie, N., Zhang, F., & Nureki, O.
- Affiliations
- The University of Tokyo (JP)
- Broad Institute (US)
- Keio University (JP)
- Research Institute for Microbial Diseases, The University of Osaka (JP)
- Research Center for Advanced Science and Technology, The University of Tokyo (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Nishimasu, Hiroshi
- Nureki, Osamu
- ORCID
- Venue
- Science
- Published
- 2018-09-21
- Volume
- 361
- Issue
- 6408
- Pages
- 1259-1262
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6368452
- OpenAlex
- W2889513238
- Cited by
- 1,100
- References
- 25
- Citations by year
- 2026: 81 · 2025: 113 · 2024: 143 · 2023: 134 · 2022: 167 · 2021: 169 · 2020: 156 · 2019: 125 · 2018: 11
- FWCI
- 41.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Japan Agency for Medical Research and Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, protospacer adjacent motif, crystal structure, indels, C-to-T conversion, activation-induced cytidine deaminase, targeted mutagenesis
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, Bacterial Proteins, Endonucleases, Humans, Protein Engineering, Crystallography, X-Ray, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review